These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 5650324

  • 1. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH, Stenlund RR, Corliss RJ, Sialer S, Rowe GG.
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract] [Full Text] [Related]

  • 2. Comparative profile of L 3428 and other antianginal agents on cardiac hemodynamics.
    Petta JM, Zaccheo VJ.
    J Pharmacol Exp Ther; 1971 Feb; 176(2):328-38. PubMed ID: 4998691
    [No Abstract] [Full Text] [Related]

  • 3. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T, Tachikawa S.
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract] [Full Text] [Related]

  • 4. Systemic and coronary hemodynamic effects of perhexiline.
    Rowe GG, Spring DA, Afonso S.
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275
    [No Abstract] [Full Text] [Related]

  • 5. [Experimental research on the coronary dilatory action of benzydryl-1-piperonylpiperazine in the intact dog].
    Laubie M, Schmitt H.
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):1-6. PubMed ID: 5834935
    [No Abstract] [Full Text] [Related]

  • 6. Coronary and systemic hemodynamic effects of propranolol and practolol compared in the resting, conscious dog.
    Andres JF, White FC, Bloor CM.
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):481-4. PubMed ID: 4818387
    [No Abstract] [Full Text] [Related]

  • 7. Enhancement of coronary vasodilator action of nicotinamide adenine dinucleotide by lidoflazine.
    Afonso S, O'Brien GS, Berndt TB, Ansfield TJ, Rowe GG.
    J Pharmacol Exp Ther; 1971 Dec; 179(3):573-9. PubMed ID: 4333026
    [No Abstract] [Full Text] [Related]

  • 8. [Physiology of coronary circulation as the basis for the evaluation of coronary dilator agents].
    Lochner W.
    Arzneimittelforschung; 1970 Mar; 20():424-32. PubMed ID: 4989252
    [No Abstract] [Full Text] [Related]

  • 9. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
    Hansing CE, Folts JD, Afonso S, Rowe GG.
    J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparative animal experimental studies of the effectivity of various blood vessel and myocardium ACTIVE SUBSTANCES IN AN ACUTE TRIAL].
    Urbaszek W, Kalkowski H, Günther K, Splith G, Trenckmann H.
    Z Gesamte Inn Med; 1969 Feb 15; 24(4):102-8. PubMed ID: 4978753
    [No Abstract] [Full Text] [Related]

  • 12. Systemic and coronary hemodynamic effects of 3-(beta-diethylamino-ethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-(1,2-chromene)-hydrochloride (Intensain, A-27053).
    Rowe GG, Terry W, Stenlund RR, Thomsen JH, Querimit AS.
    Arch Int Pharmacodyn Ther; 1969 Mar 15; 178(1):99-103. PubMed ID: 5353477
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Coronary blood flow and oxygen consumption of human heart under the effect of hexobendine].
    Rudolph W, Marko I, Baubkus H, Müller-Seydlitz P, Gadomski M, Posse P, Gulde M, Jetschgo G.
    Arzneimittelforschung; 1970 May 15; 20(5):637-47. PubMed ID: 5468053
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of nerobol on blood supply of the heart, contraction ability of the myocardium and hemodynamic condition].
    Seliverstov SA.
    Farmakol Toksikol; 1969 May 15; 32(2):159-62. PubMed ID: 5772139
    [No Abstract] [Full Text] [Related]

  • 20. Hemodynamic aspects of the treatment of ischemic heart disease.
    Wellens D.
    Angiology; 1977 Dec 15; 28(12):839-43. PubMed ID: 23714
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.